newsfilter
← Latest News
GlobeNewswire·

CDT Partners with Manoira to Explore Enhancing Animal Health Products Ahead of Launch

  • CDT Equity Inc. signed an evaluation agreement with Manoira Corporation to assess clinical-stage assets AZD1656 & AZD5904 for potential integration into Manoira's animal health products.
  • Manoira plans to launch its first range of animal health products in Q1 2027 using its licensed cannabinoid cocrystal & solid-form technologies.
  • Under the agreement, CDT will provide Manoira with access to materials from AZD1656, including specific cocrystal derivatives, & AZD5904 for evaluation.
  • Manoira will test these assets to determine if they can enhance efficacy, safety, formulation, or other commercial characteristics of its planned product range.
  • If the evaluation succeeds, CDT & Manoira intend to enter licensing & commercialization discussions for the resulting products following launch.
  • CDT views this partnership as an opportunity to extend the value of its assets into the animal health sector for companion animals & livestock.
  • CDT Equity Inc. is a data-driven biopharmaceutical company leveraging AI, solid-form chemistry, & asset repositioning to advance therapeutic assets.
  • The press release includes forward-looking statements regarding future operations, product approvals, & partnership outcomes, accompanied by standard risk disclosures.